Indivior Pharmaceuticals (INDV) Short term Debt (2021 - 2025)
Historic Short term Debt for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $18.0 million.
- Indivior Pharmaceuticals' Short term Debt changed N/A to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year change of. This contributed to the annual value of $18.0 million for FY2024, which is 50000.0% up from last year.
- Indivior Pharmaceuticals' Short term Debt amounted to $18.0 million in Q3 2025.
- In the past 5 years, Indivior Pharmaceuticals' Short term Debt ranged from a high of $18.0 million in Q4 2024 and a low of $3.0 million during Q4 2021
- Its 5-year average for Short term Debt is $11.6 million, with a median of $18.0 million in 2024.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Short term Debt changed by 0.0% in 2022, and later surged by 50000.0% in 2024.
- Indivior Pharmaceuticals' Short term Debt (Quarter) stood at $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then skyrocketed by 500.0% to $18.0 million in 2024, then changed by 0.0% to $18.0 million in 2025.
- Its Short term Debt stands at $18.0 million for Q3 2025, versus $18.0 million for Q2 2025 and $18.0 million for Q1 2025.